Australian (ASX) Stock Market Forum

ADO - AnteoTech Limited

nice to see $4Million allocated to the SPP. Chances are it will be rushed, and applications scaled back.

Use of Funds Fund (A$m) ........ Capital Raising $12.0
Working capital for COVID-19 Antigen Rapid Test rollout ... 6.0
Acceleration of assay pipeline, including COVID Multiplex and Sepsis Test ... 3.0
Organisational development in support of the growing activity base of the Company ... 1.5
Battery Development program acceleration ... 0.5
Working capital and costs associated with Capital Raising ... 1.0
 
Would have expected ADO to have continue momentum on the back of this announcement on 5 may 21;

AnteoTech Limited has completed a Follow-on Equity Offering in the amount of AUD 12.000001 million.​

AnteoTech Limited has completed a Follow-on Equity Offering in the amount of AUD 12.000001 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 46,153,851 Price\Range: AUD 0.26 Discount Per Security: AUD 0.0156 Transaction Features: Subsequent Direct Listing
Based on my chart I expect things to improve and continue;
1621058696218.png
 
It's basically the path of the rest of the market falling precipitously over the past couple of weeks though stockbailz. Not to say it won't rebound from here, but I think it's just tracking/moving with the market (like everything else is) rather than anything moving it specifically.
 
It's basically the path of the rest of the market falling precipitously over the past couple of weeks though stockbailz. Not to say it won't rebound from here, but I think it's just tracking/moving with the market (like everything else is) rather than anything moving it specifically.
I agree should follow trend, and step up to the plate...XJO Nasdaq asx all been down!
 
Last edited:
Looking like a healthy return to trend:

243524356.jpg


I might nab some tomorrow.
 
Picking ADO in the June tipping comp. They are due to get the results from their Covid test which will hopefully show that their test is just as accurate using a saliva swab as it with a nasal swab.
 
Is Anteotech back into the bull market, strong gains Wed and today. Perhaps test results are in but no news yet...Wkly Chart...

1624590581707.png
 
Results from the saliva tests are now officially overdue. Good news (hopefully) should drop any day now.
 
ADO is my tip for the August tipping comp. With distributors lined up to sell ADO RAT test in England, Australia and Southeast Asia, more positive feedback for their battery technology and announcement that their sepsis test is being fast tracked this is gonna off sooner or later.
 
Picking ADO for the September tipping comp. With arguably one of the best Covid tests in the world they are due to start converting that into sales soon.
 
ADO is my tip for the August tipping comp. With distributors lined up to sell ADO RAT test in England, Australia and Southeast Asia, more positive feedback for their battery technology and announcement that their sepsis test is being fast tracked this is gonna off sooner or later.
With that been said, you would think ADO are motoring into something substantial. There only putting along slowly heading south, when you would think something good to come out of these EuGENI Agreements they keep signing with different country's around the world ..
Announced today a Agreement with Turkey. Not sure what it all means, but if its got anything to do with Covid you would think they get something out of it...

1630894504900.png

AnteoTech Ltd (ASX: ADO) (“AnteoTech” or “the Company”) is pleased to advise that it has signed a
Distribution Agreement (Agreement) with Pera Medikal Anonim Sirketi (Pera Medikal) for the
distribution of the EuGeni Reader platform and SARS-CoV-2 Antigen Rapid Diagnostic Test (RDT)1 in
Turkey.

Pera Medikal is one of Turkey's leading importors and representative companies in the field of medical
diagnostics and food analysis. They supply a broad range of medical diagnostic products to hospitals
and laboratories through a network of 15 dealers across Turkey.

1630894721828.png
 
It'll be interesting to see if ADO can benefit from the public desire for the Covid rapid antigen tests. Legislation needs to be changed and the TGA has to issue approval. The public demand seems to be strong.

The recent rally in ADO seems to be anticipating the regulatory approval.
 
ADO has finally lodged their application for TGA approval for their 15minute Covid test. The recent investors webinar was was quite optimistic about progress with ADO's battery technology. Fast tracking their sepsis test also bodes well for the future. This company has been significantly derisked this year and if they can just work on their sales and marketing they will become a global player.
 
Top